MMBG Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.9M Buy
9,070
+123
+1% +$126K 0.86% 23
2026
Q1
$8.23M Buy
8,947
+570
+7% +$578K 0.76% 29
2025
Q4
$9M Buy
8,377
+8
+0.1% +$7.65K 0.76% 29
2025
Q3
$6.39M Buy
8,369
+3,530
+73% +$2.63M 0.57% 35
2025
Q2
$3.77M Buy
4,839
+1,805
+59% +$1.4M 0.38% 49
2025
Q1
$2.51M Buy
3,034
+1,469
+94% +$1.22M 0.28% 54
2024
Q4
$1.21M Buy
+1,565
New +$1.3M 0.13% 80

Other funds holding LLY

MMBG Investment Advisors's LLY Position: Q2 2026 in Review

MMBG Investment Advisors increased its Eli Lilly (LLY) stake by 1.4% in Q2 2026, buying an estimated $126K and bringing the position to 9,070 shares worth $10.9M. The position accounts for 0.86% of the portfolio, ranked #23.

MMBG Investment Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • MMBG Investment Advisors held 9,070 shares of Eli Lilly worth $10.9M as of Q2 2026.
  • MMBG Investment Advisors bought 123 Eli Lilly shares in Q2 2026, an estimated $126K.
  • Eli Lilly made up 0.86% of MMBG Investment Advisors's portfolio in Q2 2026, its #23 holding.
  • MMBG Investment Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on MMBG Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.